ART5803: Clinical Trials

1 trial of ART5803, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow ART5803: new trials by email Literature Review of ART5803 trials Research Report on ART5803

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease
ART5803, ART5803-Cohort D - Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease
Phase 2RecruitingArialys Australia Pty Ltd302026-05-152026-10-27

Conditions studied

Autoimmune Diseases of the Nervous System (1)  ·  Encephalitis (1)

Sponsors

Arialys Australia Pty Ltd (1)

Countries

South Korea (1)

Top investigators

Pete Flynn, PhD (1)